arrow
M

Maria A. González-Carmona

University of Bonn
H指数:24
被引数:2,543

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)

序贯或 upfront 三联疗法(durvalumab、tremelimumab 和 bevacizumab)用于不可切除的肝细胞癌患者的方案:MONTBLANC 试验方案(AIO-HEP-0325/ass)

2026-02-200
PRE
Clinical practice and implications of biomarker testing in biliary tract cancer: an observational study☆

胆道癌中生物标志物检测的临床实践与意义:一项观察性研究☆

2025-11-040
OAAI
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in Germany

改进肿瘤委员会决策的实施: 德国的一项回顾性单中心观察性研究

IN VIVO
IF1.8
2025-11-010
PRE
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures

胃肠道癌症患者中SARS-CoV-2疫苗接种和感染的纵向研究:通过变异株适应性抗原暴露稳定免疫应答并中和新兴变异株

2024-12-190
OA
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort

阿特珠单抗/贝伐单抗和乐伐替尼治疗肝细胞癌: 欧洲真实世界队列的比较分析

2024-11-013
OAAI
The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma

来伐替尼对晚期不可切除肝细胞癌患者肌肉减少症的影响

2024-09-270
OAAI
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort
2024-09-202
OAAI
Study Protocol of a Randomized, Two-Arm, Phase I/II Trial Investigating the Feasibility, Safety, and Efficacy of Local Treatment with US-Guided High-Intensity Focused Ultrasound in Combination with Palliative Chemotherapy in Inoperable Pancreatic Cancer
2024-06-260
OAAI
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis
2024-03-010
OAAI
Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy
2023-08-292
OAAI
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)

一项开放标签,单臂II期试验的研究方案,该试验研究了三氟尿苷/替匹拉西联合伊立替康作为胆管癌 (TRITICC) 患者二线治疗的疗效和安全性

2023-05-223
OAAI
Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real-world cohort

在大型真实队列中,围手术期使用FLOT4治疗可显着提高胃食管癌和胃癌患者的生存率

2023-05-056
OA
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy
2023-02-1711
OAAI